MedPath

Universidad Peruana Cayetano Heredia

🇵🇪Peru
Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

48

Active:2
Completed:32

Trial Phases

5 Phases

Early Phase 1:1
Phase 1:1
Phase 2:8
+2 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (45 trials with phase data)• Click on a phase to view related trials

Not Applicable
30 (66.7%)
Phase 2
8 (17.8%)
Phase 3
5 (11.1%)
Early Phase 1
1 (2.2%)
Phase 1
1 (2.2%)

Text Messaging to Promote HIV Testing in Gay Men

Not Applicable
Completed
Conditions
HIV Testing
First Posted Date
2025-09-10
Last Posted Date
2025-09-10
Lead Sponsor
Universidad Peruana Cayetano Heredia
Target Recruit Count
400
Registration Number
NCT07165496
Locations
🇵🇪

Universidad Peruana Cayetano Heredia, Lima, Lima Province, Peru

Implementation of the COmmunity HEalth System InnovatiON Project in Low- and Middle- Income Countries

Not Applicable
Not yet recruiting
Conditions
Hypertension
Diabetes Mellitus
Neglected Tropical Diseases
First Posted Date
2025-05-25
Last Posted Date
2025-05-25
Lead Sponsor
Universidad Peruana Cayetano Heredia
Target Recruit Count
2094
Registration Number
NCT06989502
Locations
🇲🇿

Eduardo Mondlane University, Maputo, Mozambique

🇳🇵

B.P. Koirala Institute of Health Sciences, Dharān Bāzār, Nepal

🇵🇪

Universidad Peruana Cayetano Heredia, Piura, Peru

Oxfendazole in Mild Parenchymal Brain Cysticercosis

Phase 2
Not yet recruiting
Conditions
Brain Cysticercosis
Interventions
First Posted Date
2024-08-22
Last Posted Date
2024-11-01
Lead Sponsor
Universidad Peruana Cayetano Heredia
Target Recruit Count
544
Registration Number
NCT06565507

WhatsApp Intervention to Assess the Effect of Messages in Adherence to Antiretrovirals in Young People with HIV in Peru

Not Applicable
Active, not recruiting
Conditions
HIV
First Posted Date
2024-07-15
Last Posted Date
2025-03-26
Lead Sponsor
Universidad Peruana Cayetano Heredia
Target Recruit Count
131
Registration Number
NCT06500013
Locations
🇵🇪

Hospital Cayetano Heredia, Lima, Peru

One and Two Doses of Oxfendazole Versus a Schedule of Two Doses of Triclabendazole in Chronic Fascioliasis

Phase 2
Not yet recruiting
Conditions
Fascioliasis
Interventions
First Posted Date
2024-04-16
Last Posted Date
2025-06-17
Lead Sponsor
Universidad Peruana Cayetano Heredia
Target Recruit Count
336
Registration Number
NCT06367361
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 10
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.